Aethlon Medical Inc expected to post a loss of 21 cents a share - Earnings Preview

Aethlon Medical

10/02/2025 21:52

* Aethlon Medical Inc  AEMD.OQ   AEMD.O  is expected to show
no
change in quarterly revenue when it reports  results on February
12 for the period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Aethlon Medical Inc is
for a
loss of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aethlon
Medical
Inc is $3.86​, above​ its last closing price of $0.72. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.20       -0.19      -0.20     Missed  -2.6
 Jun. 30 2024  -0.31       -0.31      -0.34     Missed  -7.9
 Mar. 31 2024  -1.41       -1.23      -0.91     Beat    26​
 Dec. 31 2023  -1.23       -1.23      -1.37     Missed  -11.4
 ​​Sep.        -1.30       -1.40      -1.22     Beat    12.9
 30 2023                                                
 Jun. 30 2023  -1.20       -1.30      -1.40     Missed  -7.7​
 Mar. 31 2023              -1.30      -1.00     Beat    23.1
 Dec. 31 2022  -0.81       -0.80      -1.20     Missed  -50
 This summary was machine generated February 10 at 21:52 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)